Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
A business making money today isn’t necessarily a winner, which is why we analyze companies across multiple dimensions at StockStory. Keeping that in mind, here is one profitable company that leverages its financial strength to beat the competition and two best left off your watchlist.
Two Stocks to Sell:
CBRE (CBRE)
Trailing 12-Month GAAP Operating Margin: 4.7%
Established in 1906, CBRE (NYSE: CBRE) is one of the largest commercial real estate services firms in the world.
Why Do We Think CBRE Will Underperform?
- The company has faced growth challenges as its 12% annual revenue increases over the last five years fell short of other consumer discretionary companies
- Low free cash flow margin of 2.9% for the last two years gives it little breathing room, constraining its ability to self-fund growth or return capital to shareholders
- Eroding returns on capital from an already low base indicate that management’s recent investments are destroying value
At $127.97 per share, CBRE trades at 16.3x forward P/E. Dive into our free research report to see why there are better opportunities than CBRE.
Inspire Medical Systems (INSP)
Trailing 12-Month GAAP Operating Margin: 7.3%
Offering an alternative for the millions who struggle with traditional CPAP machines, Inspire Medical Systems (NYSE: INSP) develops and sells an implantable neurostimulation device that treats obstructive sleep apnea by stimulating nerves to keep airways open during sleep.
Why Does INSP Worry Us?
- Subscale operations are evident in its revenue base of $915.2 million, meaning it has fewer distribution channels than its larger rivals
- Estimated sales decline of 8.3% for the next 12 months implies a challenging demand environment
Inspire Medical Systems’s stock price of $40.58 implies a valuation ratio of 40.6x forward P/E. To fully understand why you should be careful with INSP, check out our full research report (it’s free).
One Stock to Watch:
Flywire (FLYW)
Trailing 12-Month GAAP Operating Margin: 5%
Initially created to solve the challenges of international student tuition payments, Flywire (NASDAQ: FLYW) provides specialized payment processing and software solutions that help educational institutions, healthcare systems, travel companies, and businesses manage complex payments.
Why Could FLYW Be a Winner?
- Average billings growth of 36.5% over the last year enhances its liquidity and shows there is steady demand for its products
- Operating margin of 5% highlights its superior profitability versus many of its software peers, and it boosted its profits by achieving some fixed cost leverage
- Free cash flow margin of 23% is higher than many in the industry, giving it breathing room and optionality
Flywire is trading at $15.32 per share, or 2.8x forward price-to-sales. Is now a good time to buy? Find out in our full research report, it’s free.
Stocks We Like Even More
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
